Regulatory and Market Considerations of Recent Part D Rebate Regulations by Alvarez & Marsal
Part I: A look at HHS, the Latest COVID-19 Relief Bill and What the Next Two Years Means for Democrats and Republicans In this...
Part II: President Biden’s COVID-19 Plan, Campaign Promises Around Healthcare and What’s to Come for Prescription Drug Pricing In this 3-part series, you will...
The Rise of Telehealth Amidst a Global Pandemic: Part II – Addressing Regulatory and Compliance Risk by Alvarez & Marsal